Veeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.
Follow VEEV
Veeva Systems Inc. (VEEV) EV/EBITDA
As of 16 October 2026, Veeva Systems Inc. (VEEV) trades at a EV/EBITDA of 39.7×. Over the past ten years it has ranged from 17.6× (June 2026) to 123× (October 2020); the current reading is higher than 23% of that period. That is above the Health Information Services industry median of 11.5× and above the Healthcare sector median of 9.2×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2026 | 27.8× | (38.45%) |
| FY2025 | 45.2× | (29.99%) |
| FY2024 | 64.5× | 39.72% |
| FY2023 | 46.2× | (22.94%) |
| FY2022 | 59.9× | (36.94%) |
| FY2021 | 95.0× | 49.28% |
| FY2020 | 63.7× | 9.95% |
| FY2019 | 57.9× | 36.69% |
| FY2018 | 42.4× | 22.04% |
| FY2017 | 34.7× | 8.72% |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Jul 2026 | 23.8× | 31.56% |
| Apr 2026 | 18.1× | (34.92%) |
| Jan 2026 | 27.8× | (38.89%) |
| Oct 2025 | 45.5× | (4.54%) |
| 43 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| TEM Tempus AI, Inc. compare | n/m |
| HTFL Heartflow, Inc. compare | n/m |
| TXG 10x Genomics compare | n/m |
| WAY Waystar Holding Corp. compare | 14.9× |
| HQY HealthEquity, Inc. compare | 16.4× |
| DOCS Doximity, Inc. compare | 22.8× |
| BTSG BrightSpring Health Services, Inc. compare | 22.9× |
| VEEV Veeva Systems Inc. | 39.7× |
| HNGE Hinge Health Inc. compare | 46.2× |
| Health Information Services industry median | 11.5× |
| Healthcare sector median | 9.2× |
| Market median | 11.0× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on VEEV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement